Alexander Cumbo Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alexander Cumbo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alexander Cumbo. Alexander Cumbo is EVP, Chief Commercial Officer in Sarepta Therapeutics, Inc. ($SRPT) and SVP, Chief Commercial Officer in Sarepta Therapeutics, Inc. ($SRPT) and VP, Head of Commercial in Sarepta Therapeutics, Inc. ($SRPT) and Director in Ra Pharmaceuticals, Inc. ($RARX).
Latest Insider Trading Transactions of Alexander Cumbo
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Cumbo Alexander | Director | Option Exercise | D | 12.99 | 25,000 | 324,750 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Cumbo Alexander | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | A | 114.47 | 37,500 | 4,292,625 | 37,500 | |
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,700 | 0 | 8,567 | 1.9 K to 8.6 K (+358.86 %) |
| Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | M | 26.24 | 26,084 | 684,444 | 20,881 | |
| Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | M | 13.71 | 3,895 | 53,400 | 0 | |
| Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | M | 13.71 | 2,727 | 37,387 | 1,123 | |
| Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Sell | S | 125.50 | 9,294 | 1,166,397 | 1,867 | 11.2 K to 1.9 K (-83.27 %) |
| Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Sell | S | 125.50 | 32,706 | 4,104,603 | 11,161 | 43.9 K to 11.2 K (-74.56 %) |
| Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Buy | M | 26.24 | 26,084 | 684,444 | 43,867 | 17.8 K to 43.9 K (+146.68 %) |
| Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Buy | M | 13.71 | 3,895 | 53,400 | 17,783 | 13.9 K to 17.8 K (+28.05 %) |
| Dec 17 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Buy | M | 13.71 | 2,727 | 37,387 | 13,888 | 11.2 K to 13.9 K (+24.43 %) |
| Jun 13 2019 | RARX | Ra Pharmaceuticals ... | Cumbo Alexander | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
| Mar 29 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Payment of Exercise | F | 118.68 | 2,165 | 256,942 | 11,161 | 13.3 K to 11.2 K (-16.25 %) |
| Mar 29 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Grant | A | 0.00 | 4,876 | 0 | 13,326 | 8.5 K to 13.3 K (+57.70 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | A | 145.48 | 45,000 | 6,546,600 | 45,000 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Sell | D | 0.00 | 3,375 | 0 | 8,450 | 11.8 K to 8.5 K (-28.54 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 26.24 | 5,250 | 137,760 | 46,965 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.90 | 2,250 | 31,275 | 0 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 140.00 | 15,000 | 2,100,000 | 15,266 | 30.3 K to 15.3 K (-49.56 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 26.24 | 5,250 | 137,760 | 30,266 | 25 K to 30.3 K (+20.99 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.90 | 2,250 | 31,275 | 25,016 | 22.8 K to 25 K (+9.88 %) |
| Nov 15 2018 | RARX | Ra Pharmaceuticals ... | Cumbo Alexander | Director | Option Exercise | A | 12.99 | 25,000 | 324,750 | 25,000 | |
| Aug 08 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 121.02 | 6,000 | 726,120 | 22,766 | 28.8 K to 22.8 K (-20.86 %) |
| Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.90 | 11,914 | 165,605 | 2,250 | |
| Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 9,944 | 136,332 | 3,895 | |
| Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 11,924 | 163,478 | 3,850 | |
| Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 137.32 | 11,914 | 1,636,030 | 28,766 | 40.7 K to 28.8 K (-29.29 %) |
| Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.90 | 11,914 | 165,605 | 40,680 | 28.8 K to 40.7 K (+41.42 %) |
| Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 137.32 | 9,944 | 1,365,510 | 28,766 | 38.7 K to 28.8 K (-25.69 %) |
| Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 9,944 | 136,332 | 38,710 | 28.8 K to 38.7 K (+34.57 %) |
| Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 137.32 | 11,924 | 1,637,404 | 28,766 | 40.7 K to 28.8 K (-29.30 %) |
| Jul 11 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 11,924 | 163,478 | 40,690 | 28.8 K to 40.7 K (+41.45 %) |
| May 24 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 0.00 | 4,876 | 0 | 0 | |
| May 24 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 89.22 | 1,435 | 128,031 | 28,766 | 30.2 K to 28.8 K (-4.75 %) |
| May 24 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 0.00 | 4,876 | 0 | 30,201 | 25.3 K to 30.2 K (+19.25 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 26.24 | 1,370 | 35,949 | 11,415 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.90 | 835 | 11,607 | 5,001 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 54 | 740 | 6,107 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 241 | 3,304 | 1,485 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 442 | 35,899 | 25,325 | 25.8 K to 25.3 K (-1.72 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 26.24 | 1,370 | 35,949 | 25,767 | 24.4 K to 25.8 K (+5.62 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 142 | 11,533 | 24,397 | 24.5 K to 24.4 K (-0.58 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.90 | 835 | 11,607 | 24,539 | 23.7 K to 24.5 K (+3.52 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 9 | 731 | 23,704 | 23.7 K to 23.7 K (-0.04 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 54 | 740 | 23,713 | 23.7 K to 23.7 K (+0.23 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 40 | 3,249 | 23,659 | 23.7 K to 23.7 K (-0.17 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 241 | 3,304 | 23,699 | 23.5 K to 23.7 K (+1.03 %) |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
| Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 0.00 | 9,752 | 0 | 0 | |
| Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 37.88 | 3,169 | 120,042 | 23,458 | 26.6 K to 23.5 K (-11.90 %) |
| Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 0.00 | 9,752 | 0 | 26,627 | 16.9 K to 26.6 K (+57.79 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 2,500 | 34,275 | 15,774 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 41.00 | 3,418 | 140,138 | 16,875 | 20.3 K to 16.9 K (-16.84 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 41.00 | 2,500 | 102,500 | 20,293 | 22.8 K to 20.3 K (-10.97 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 2,500 | 34,275 | 22,793 | 20.3 K to 22.8 K (+12.32 %) |
| Jun 08 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | A | 34.64 | 40,000 | 1,385,600 | 40,000 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | VP, Head of Commerc ... | Option Exercise | A | 32.63 | 4,924 | 160,670 | 4,924 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | VP, Head of Commerc ... | Option Exercise | A | 32.63 | 22,576 | 736,655 | 22,576 |
Page: 1